Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 10.66B P/E - EPS this Y -4.70% Ern Qtrly Grth -
Income -453M Forward P/E 3.78 EPS next Y 13.50% 50D Avg Chg 19.00%
Sales 16.29B PEG 4.72 EPS past 5Y -0.30% 200D Avg Chg 4.00%
Dividend N/A Price/Book 1.32 EPS next 5Y 1.60% 52W High Chg -19.00%
Recommedations 2.10 Quick Ratio 0.46 Shares Outstanding 1.13B 52W Low Chg 30.00%
Insider Own 0.00% ROA 5.16% Shares Float 1.13B Beta 0.88
Inst Own 55.38% ROE -10.51% Shares Shorted/Prior 23.95M/19.50M Price 9.25
Gross Margin 49.50% Profit Margin -2.78% Avg. Volume 14,211,503 Target Price 21.14
Oper. Margin 19.62% Earnings Date Nov 6 Volume 32,973,594 Change 11.58%
About Teva Pharmaceutical Industries

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The company focuses on the central nervous system (CNS), respiratory, and oncology areas. It provides active pharmaceutical ingredients, as well as contract manufacturing services; and operates an out-licensing platform that offers a portfolio of products to other pharmaceutical companies. The company also offers BENDEKA and TREANDA injections for the treatment of chronic lymphocytic leukemia and indolent b-cell non-hodgkin's lymphoma; GRANIX; TRISENOX; LONQUEX; and TEVAGRASTIM/RATIOGRASTIM. In addition, it provides COPAXONE for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine in adults; AUSTEDO for the treatment of neurodegenerative and movement disorders associated with Huntington's disease and tardive dyskinesia; UZEDY for the treatment of schizophrenia; ProAir RespiClick inhalation powder; QVAR for treatment for asthma; BRALTUS, a long-acting muscarinic antagonist; CINQAIR/CINQAERO injection; DuoResp Spiromax, an inhaled corticosteroid and long-acting beta-agonist bronchodilator; and AirDuo RespiClick fluticasone propionate and salmeterol inhalation powder. The company offers its OTC products under SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brand names. It has collaboration agreements with MedinCell; Sanofi; Alvotech; and Biolojic Design Ltd., as well as license agreement with MODAG GmbH. The company was founded in 1901 and is based in Tel Aviv, Israel.

Teva Pharmaceutical Industries News
09/15/24 Teva Pharmaceutical Industries Limited (NYSE:TEVA) is favoured by institutional owners who hold 68% of the company
09/13/24 TEVA Stock Rises 72.5% This Year: Time to Buy, Sell or Hold?
09/11/24 Teva to Present at the Bank of America 2024 Global Healthcare Conference
09/10/24 Baltimore settles with Teva, Walgreens ahead of scheduled opioid trial
09/10/24 Sector Update: Health Care Stocks Advance Late Afternoon
09/10/24 Teva agrees to pay Baltimore City $80m for fuelling opioid epidemic
09/10/24 Update: Teva Pharmaceutical Faces Fine in EU for Dismissive Tactics Against Rivals
09/06/24 JP Morgan Shows Most Interest In Teva, Organon As Specialty Pharma Sector Exhibits Signs Of Stability
08/26/24 Teva to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
08/05/24 Teva Pharmaceutical Industries Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
08/02/24 What Are the Hottest Biotech Stocks Right Now? 3 Top Picks.
08/01/24 TEVA Q2 Earnings Beat, Generic Business Drives Sales, Stock Up
07/31/24 Teva Pharma, With A 67% Gain This Year, Flirts With A Breakout On Beat-And-Raise Report
07/31/24 Teva Pharmaceutical Industries (TEVA) Q2 2024 Earnings Call Transcript
07/31/24 Teva Pharmaceutical Industries (TEVA) Reports Q2 Earnings: What Key Metrics Have to Say
07/31/24 Is Teva Pharmaceutical Industries (TEVA) Stock Undervalued Right Now?
07/31/24 Teva Announces Strong Growth in Second Quarter Revenues mainly driven by Generics Products in All Regions and AUSTEDO®; Raises 2024 Financial Guidance
07/29/24 Hospital Business Recovery to Aid Haemonetics' (HAE) Q1 Earnings
07/29/24 Unveiling Teva Pharmaceutical Industries (TEVA) Q2 Outlook: Wall Street Estimates for Key Metrics
07/25/24 Teva and Sanofi Announce Accelerated Timeline for Anti-TL1A Phase 2b Program in Patients with Inflammatory Bowel Disease
TEVA Chatroom

User Image Terrordomo80 Posted - 6 hours ago

$TEVA what a piece....

User Image Winning_calls Posted - 20 hours ago

$TEVA pick me up @ $18.5🫠🫠🫠

User Image NNJAWINLIVE Posted - 2 days ago

$TEVA

User Image Trader_Ty Posted - 3 days ago

$TEVA Weekly hammer looking good

User Image TheDudeRooster Posted - 3 days ago

$TEVA In my sleep. ADL priced in at $19.90 and climbing. 400 /CALL TEVA 19.00 EXP 12-20-24 $1.2553 Last updated at 02:47 PM ET $1.26

User Image TheDudeRooster Posted - 3 days ago

$TEVA I couldn't help myself after the channel recapture 300/CALL TEVA 19.00 EXP 12-20-24/$1.26 Last updated at 02:13 PM ET $1.26

User Image Longaeva_Capital Posted - 3 days ago

$TEVA vtrs another generics play with alpha and a 4% div. Will rebound with the generics rebound

User Image Longaeva_Capital Posted - 3 days ago

$TEVA probably going to consolidate in this range into earnings where we will eventually go 22+

User Image LakersandVRX Posted - 3 days ago

$TEVA can we pls not see 17 anymore. It was good while it lasted but now it has become a toxic relationship. Both 17 and Teva need to move on from here.

User Image tkstockpicker Posted - 3 days ago

$TEVA 💪

User Image StockInvest_us Posted - 3 days ago

Signal alert: $TEVA - GoldenStar https://stockinvest.us/l/QMUsYykC3p

User Image Notashort45 Posted - 4 days ago

$TEVA let's get to $22 a share.

User Image Hopewisper Posted - 4 days ago

$TEVA Your only gain is on your ...🙈

User Image Hopewisper Posted - 4 days ago

$TEVA Ohhh.... ther is. We will end up with a nice yield and more a lot more green ahead🤩🤑

User Image Trader_Ty Posted - 4 days ago

$TEVA Right off the 50 and back over resistance. Could be an add back today

User Image NNJAWINLIVE Posted - 4 days ago

$TEVA nice dipp 17.01

User Image Gemineye Posted - 4 days ago

$TEVA bought this so many years ago I forgot! Maybe when I’m 100 I’ll break even? 🤣

User Image TeresaTrades Posted - 4 days ago

Largest PUT OI decreases $SIRI $APA $TEVA $NVDA $CARR

User Image TeresaTrades Posted - 4 days ago

Largest PUT OI increases $AAL $DKNG $NVDA $APA $TEVA

User Image TeresaTrades Posted - 4 days ago

Largest CALL OI decreases $NVDA $WMT $CHPT $TEVA $AMD

User Image JaredSotken Posted - 4 days ago

$TEVA Steady.

User Image NNJAWINLIVE Posted - 4 days ago

$TEVA 💪 N LONG!!

User Image Longaeva_Capital Posted - 5 days ago

$TEVA rising tides

User Image LakersandVRX Posted - 5 days ago

$TEVA market correction seems to have taken place. Too late to sell now cause 20s are coming….maybe later than planned. Although, just when I think all is lost, Teva comes back strong.

User Image smartkarma Posted - 5 days ago

$TEVA | Teva - ESG Report - Lucror Analytics "Lucror Analytics' ESG Scores are based on a 3-tiered scale and are adjusted for Controversies (if applicable). We assess Teva's ESG as "Adequate",..." - Leonard Law, CFA (Lucror Analytics) Read more: https://www.smartkarma.com/insights/teva-esg-report-lucror-analytics-91f3bc74-c6ea-4900-9bd6-d5b13fad8ddb

User Image Article_AI Posted - 6 days ago

$TEVA Baltimore settles with Teva, Walgreens ahead of scheduled opioid trial Baltimore said on Tuesday that it has settled with Walgreens over claims that the pharmacy operator fueled opioid addiction in the Maryland city, the latest in a series of settlements totaling $402.5 million ahead of a trial scheduled to begin next week. https://www.stck.pro/news/TEVA/88890993/

User Image StockRedBaron Posted - 6 days ago

$TEVA Teva Pharma Set to Be Hit With Antitrust Fine in EU, Bloomberg Reports ..GOOD. The way they screwed over $VNDA, they deserve it!

User Image Terrordomo80 Posted - 6 days ago

$TEVA Sinking shippy folks... they got it to 19 and buyers are exhausted...no telling where they'll end up now...

User Image Article_AI Posted - 6 days ago

$TEVA Exclusive: Teva faces EU fine for disparaging rival multiple sclerosis medicine, sources say Teva , the world's largest generic drugmaker, will be hit with an EU antitrust fine in the coming weeks for disparaging a rival product to its blockbuster multiple sclerosis medicine Copaxone, people with direct knowledge of the matter said on Tuesday. https://www.stck.pro/news/TEVA/88876838/

User Image NNJAWINLIVE Posted - 6 days ago

$TEVA I WILL BUY THIS DIP THANKS EU SEE YOU @ 40

Analyst Ratings
UBS Buy Sep 3, 24
Barclays Overweight Aug 1, 24
UBS Buy Jul 10, 24
Jefferies Buy Jun 27, 24
Barclays Overweight Jun 5, 24
B of A Securities Buy May 30, 24
Piper Sandler Overweight May 13, 24
Barclays Overweight May 9, 24
JP Morgan Neutral Mar 8, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Weiss Amir Chief Accounting Off.. Chief Accounting Officer Feb 01 Sell 12.3703 31,766 392,955 10,676 02/05/24
Hughes Eric A See "Remarks" See "Remarks" Aug 01 Sell 8.3 52,742 437,759 08/03/23
Kalif Eliyahu Sharon EVP, Chief Financial.. EVP, Chief Financial Officer Aug 22 Sell 10.0666 55,500 558,696 9,376 08/24/22
Stark David Matthew Exec. VP Chief Legal.. Exec. VP Chief Legal Officer Jul 28 Sell 9.0365 58,163 525,590 2,974 07/29/22
Fridriksdottir Hafrun Executive VP, Global.. Executive VP, Global R&D May 17 Sell 8.2159 130,000 1,068,067 1,387 05/19/22
Drape Eric Executive VP Global.. Executive VP Global Operations Mar 04 Sell 7.44 34,792 258,852 78,072 03/08/22
Dethlefs Sven EVP, North America C.. EVP, North America Commercial Mar 04 Sell 7.42 10,897 80,856 165,381 03/08/22
Daniell Richard Exec. VP, European C.. Exec. VP, European Commercial Mar 04 Sell 7.44 58,952 438,603 43,182 03/08/22
Stark David Matthew Exec. VP Chief Legal.. Exec. VP Chief Legal Officer Feb 28 Sell 8.14 6,452 52,519 21,380 03/02/22
Shani Eli EVP,Global Marketing.. EVP,Global Marketing&Portfolio Feb 28 Sell 8.14 5,311 43,232 9,091 03/02/22
Fridriksdottir Hafrun Executive VP, Global.. Executive VP, Global R&D Feb 28 Sell 8.14 7,590 61,783 65,509 03/02/22
Drape Eric Executive VP Global.. Executive VP Global Operations Feb 28 Sell 8.14 9,797 79,748 45,830 03/02/22
Dethlefs Sven EVP, North America C.. EVP, North America Commercial Feb 28 Sell 8.14 4,862 39,577 99,457 03/02/22
Daniell Richard Exec. VP, European C.. Exec. VP, European Commercial Feb 28 Sell 8.14 20,598 167,668 20,280 03/02/22
Stark David Matthew Exec. VP Chief Legal.. Exec. VP Chief Legal Officer Feb 08 Sell 9.06 6,110 55,357 9,402 02/10/22
Stark David Matthew Exec. VP Chief Legal.. Exec. VP Chief Legal Officer May 13 Sell 10.22 37,884 387,174 2,974 05/13/21
Drape Eric Executive VP Global.. Executive VP Global Operations May 13 Sell 10.22 19,804 202,397 73,128 05/13/21
Nazzi Gianfranco EVP, International M.. EVP, International Markets Mar 08 Sell 10.58 12,935 136,852 03/08/21
Drape Eric Executive VP Global.. Executive VP Global Operations Mar 08 Sell 10.58 6,183 65,416 55,048 03/08/21
Dethlefs Sven EVP Global Marketing.. EVP Global Marketing&Portfolio Mar 08 Sell 10.57 6,012 63,547 77,976 03/08/21
Nazzi Gianfranco EVP, International M.. EVP, International Markets Mar 04 Sell 10.88 1,400 15,232 03/04/21
Fridriksdottir Hafrun Executive VP, Global.. Executive VP, Global R&D Feb 17 Sell 11.12 2,098 23,330 103,294 02/17/21
O'Grady Brendan P. EVP, North America C.. EVP, North America Commercial Feb 11 Sell 12.69 20,694 262,607 78,146 02/11/21
Dethlefs Sven EVP Global Marketing.. EVP Global Marketing&Portfolio Feb 11 Sell 12.69 29,657 376,347 59,404 02/11/21
Daniell Richard Exec. VP, European C.. Exec. VP, European Commercial Sep 10 Sell 8.98 333 2,990 10,765 09/10/20